American Bio Medica Corp (ABMC)

[Karlchen]

this is excactly the worst ever seen words on risk and forwardlooking statements , a CEO ever has written and therefore THIS GIRL SHOULD PLAY WITH HER DOLLS OR STAND IN A KITCHEN remove her
She could have additionally said, that, even there where never an earthquake in this district, but it could happen that an earthquake occure, right in that time every employer of abmc is onsite and all people could die

That we climb so f...n nicely IS A MIRACLE and only This board deserves thanks for it ! ! !

[/This release may contain forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ, and such differences could be material. Such risks and uncertainties include, but are not limited to, risks and uncertainties related to the following: continued acceptance of our products, increased levels of competition in our industry, acceptance of new products, future sales and profit levels of the rapid antibody test for Covid-19 that we are distributing, product development, compliance with regulatory requirements, including but not limited to our ability to obtain marketing clearance on our product for our intended markets, intellectual property rights, our dependence on key personnel, third party sales and suppliers, trading in our common shares may be subject to “penny stock” rules, our history of recurring net losses and our ability to continue as a going concern. There can be no assurance that the Company will be successful in addressing such risks and uncertainties and the Company assumes no duty to update any forward-looking statements based upon actual results. Investors are strongly encouraged to review the section entitled “Risk Factors” in the Company's annual report on Form 10-K for the year ended December 31, 2018, quarterly reports on Form 10-Q, and other periodic reports on file with the Securities and Exchange Commission for a discussion of risks and uncertainties that could affect operating results and the market price of the Company's common shares. quote]